Pathogenetic reasons for use of hepatoprotector with approval clinical efficancy – ursodeoxycholic ACID: from discovery history to evidence base

Author: Gubergrits N. B., President of the Ukrainian Club of Pancreatologists, member of the Council of the European Club of Pancreatologists and the International Association of Pancreatologists, elected President of the European Club of Pancreatologists (2016), multiple winner of the European Club of Pancreatologists and the International Association of Pancreatologists, Doctor of Medical Sciences, Professor


Despite the wide choice among UDCA preparations, today’s economic realities pose the task for the practitioner to choose the drug that is optimal in terms of price-quality ratio. Choludexan (World Medicine, UK) is a worthy representative among UDCA preparations — a generic drug of European quality. It has a convenient dosage and release form – capsules of 300 mg No. 20, which allows the doctor to adhere to the average recommended dosages in treatment regimens for the vast majority of indications.

Published in a journal «District doctor» february’2017

ARTICLES FROM CATEGORY
Support of educational events. Participation of World Medicine in the First Congress of Optometrists of Ukraine.
Cetirizine is an effective and safe antihistamine (literature review, results of clinical researches)
All-Ukrainian Scientific and Practical Conference “Aspects of Internal Medicine in Wartime 2024"

CARD-NOTIFICATION OF AN ADVERSE DRUG REACTION AND/OR LACK OF EFFICACY OF THE MEDICINE

INFORMATION ABOUT THE PATIENT

SUSPECTED AR/LE

Suspected AR (describe each clinical manifestation of the AR with dates and times of onset and end and outcome)/Indication of the LE

INFORMATION ABOUT SUSPECTED MEDICINES

INFORMATION ABOUT RELATED MEDICINES

(with the exception of drugs used to correct the effects of AR/LE)
(concomitant diagnoses, laboratory and instrumental studies, allergy history, pregnancy with gestational age, method of conception, pregnancy outcome (if the pregnancy ended, the date of delivery, type of delivery, etc.)

Information about the messenger

INFORMATION ABOUT THE MEDICAL/PHARMACY SPECIALIST

(if not the notifier)

MESSAGE CARD for the patient

to provide the patient and/or his/her representative with information on adverse drug reactions and/or lack of efficacy of the drug

INFORMATION ABOUT THE PATIENT

Information about the suspected medicine

Information on the prescription of the suspected medicinal product

Information about the messenger

Information about the physician, healthcare facility and place of residence of the patient who had an adverse medicine reaction and/or lack of efficacy of the medicine

розробка сайту Estetic web design